VALID Therapeutics
PrivateCompany Overview
VALID Therapeutics is a drug discovery company that integrates complex, disease-relevant in-vitro models with human genetics and AI-driven data to increase the success of drug discovery.
Sector
AI, Data & Cloud Infrastructure
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Data as a Service
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VALID Therapeutics Comparables
Compare VALID Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Greenstone Bio | 89% | |
| pixlbio | 86% | |
| Vesalius Therapeutics | 83% | |
VALID Therapeutics Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 25, 2026
Grew 23% QoQ from 13 to 16 employees.
- Jan 24, 2026
Grew 45% QoQ from 11 to 16 employees.
VALID Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about VALID Therapeutics's valuation, stock price, and market status.